Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-9-12
|
pubmed:abstractText |
In the period from August 1991 to August 1994, the Dutch Slide Review Committee of Adult Leukemias classified 14 leukemias as AML-M0. We reviewed the clinical characteristics and response to therapy of these patients. Eight patients were male. Patients' age ranged from 7 to 77 years (medium age 62 years). There was a striking homogeneity in morphological appearance of the blasts, being small to medium-sized round cells with often an eccentric nucleus with fine chromatin, several distinct nucleoli, and a high nucleo-cytoplasmic ratio. In addition to myeloid-associated markers such as CD13 and CD33, the blasts of all patients were positive for CD34 and HLA-DR, pointing to their immature differentiation stage. TdT was present in the blasts of 71%, CD7 was positive in the blasts of 42% of the patients. No consistent cytogenetic abnormalities were found. With respect to the treatment outcome, four patients achieved a complete remission after remission-induction treatment. The median survival was 4.5 months. Our present study shows AML-M0 to be an immature leukemia, uniform in morphology and immunological phenotype, with no consistent cytogenetic phenotype and with a poor clinical outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0939-5555
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
297-300
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:7632808-Acute Disease,
pubmed-meshheading:7632808-Adult,
pubmed-meshheading:7632808-Aged,
pubmed-meshheading:7632808-Child,
pubmed-meshheading:7632808-Female,
pubmed-meshheading:7632808-Humans,
pubmed-meshheading:7632808-Immunophenotyping,
pubmed-meshheading:7632808-Leukemia, Myeloid,
pubmed-meshheading:7632808-Male,
pubmed-meshheading:7632808-Middle Aged,
pubmed-meshheading:7632808-Survival Analysis
|
pubmed:year |
1995
|
pubmed:articleTitle |
AML-MO: clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Dutch Slide Review Committee of Leukemias in Adults.
|
pubmed:affiliation |
Dr. Daniel den Hoed Cancer Center, Department of Hematology, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|